Reference Scale Average Bioequivalence Approach: ANVISA, Brazil [Regulatives / Guidelines]

posted by Maitri – India, 2018-09-21 21:49 (2042 d 12:10 ago) – Posting: # 19297
Views: 2,436

Hello,

Can any one comment on acceptability of Reference Scale Bioequivalence Approach for ANVISA ( Regulatory agency of Brazil) for highly variable drugs? Do they accept RSABE study design for Highly variable drug compounds?

Thanks & Regards,
Maitri Sanghavi

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,656 registered users;
113 visitors (0 registered, 113 guests [including 6 identified bots]).
Forum time: 09:59 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5